The receptor-dependent LQTA-QSAR: application to a set of trypanothione reductase inhibitors

A new Receptor - Dependent LQTA - QSAR approach, RD - LQTA - QSAR , is proposed as a new 4D-QSAR method. It is an evolution of receptor independent LQTA-QSAR. This approach uses the free GROMACS package to carry out molecular dynamics simulations and generates a conformational ensemble profile for e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of computer-aided molecular design 2012-09, Vol.26 (9), p.1055-1065
Hauptverfasser: Barbosa, Euzébio G., Pasqualoto, Kerly Fernanda M., Ferreira, Márcia M. C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A new Receptor - Dependent LQTA - QSAR approach, RD - LQTA - QSAR , is proposed as a new 4D-QSAR method. It is an evolution of receptor independent LQTA-QSAR. This approach uses the free GROMACS package to carry out molecular dynamics simulations and generates a conformational ensemble profile for each compound. Such an ensemble is used to build molecular interaction field-based QSAR models, as in CoMFA. To show the potential of this methodology, a set of 38 phenothiazine derivatives that are specific competitive T. cruzi trypanothione reductase inhibitors, was chosen. Using a combination of molecular docking and molecular dynamics simulations, the binding mode of the phenotiazine derivatives was evaluated in a simulated induced fit approach. The ligands alignments were performed using both ligand and binding site atoms, enabling unbiased alignment. The models obtained were extensively validated by leave- N -out cross-validation and y -randomization techniques to test for their robustness and absence of chance correlation. The final model presented Q 2 LOO of 0.87 and R ² of 0.92 and a suitable external prediction of = 0.78. The adapted binding site obtained is useful to perform virtual screening and ligand structure-based design and the descriptors in the final model can aid in the design new inhibitors.
ISSN:0920-654X
1573-4951
DOI:10.1007/s10822-012-9598-2